Shawn Cross

Insider Reports History

Location
Washington, DC
Signature
/s/ Kristen Williams, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shawn Cross:

Form 4 holding Director

Cyclo Therapeutics, Inc.

Security class
Common Stock
Shares / value
136,346
Estimated value
$85,898
Report date
27 Feb 2025
Price
$0.6300
Ownership
Direct
Form 4 holding Chief Financial Officer

Pacira BioSciences, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
150,000
Estimated value
Report date
23 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Cyclo Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
15,562
Estimated value
Report date
03 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CEO & Chair of the Board, Director

Applied Molecular Transport Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
27 Dec 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Shawn Cross

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .